Dr. Christofides is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
72 W 3rd Ave
Columbus, OH 43201Phone+1 614-453-9999
Education & Training
- Louisiana State University School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2000
- Mount Carmel Health SystemResidency, Internal Medicine, 1995 - 1998
- Ohio State University College of MedicineClass of 1995
- The Ohio State UniversityB.S., Zoology, 1987 - 1991
Certifications & Licensure
- CA State Medical License 2024 - 2026
- CO State Medical License 2019 - 2025
- OH State Medical License 1996 - 2025
- FL State Medical License 2021 - 2023
- MI State Medical License 2017 - 2018
- LA State Medical License 2000 - 2001
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- First Place Award Research Day 1999-2000
- Flame award for clinical excellence 1997
- Presentation Award College of Biological Sciences Honors Research Colloquium 1991
- Join now to see all
Clinical Trials
- An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
- Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus Start of enrollment: 2014 Mar 01
- Gan & Lee Insulin Glargine Target Type (1) Evaluating Research Start of enrollment: 2017 Oct 31
- Join now to see all
Publications & Presentations
PubMed
- 90 citationsAmerican Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update.Susan L Samson, Priyathama Vellanki, Lawrence Blonde, Elena A Christofides, Rodolfo J Galindo
Endocrine Practice. 2023-05-01 - 30 citationsOptimal Early Diagnosis and Monitoring of Diabetic Kidney Disease in Type 2 Diabetes Mellitus: Addressing the Barriers to Albuminuria Testing.Elena A. Christofides, Niraj Desai
Journal of Primary Care & Community Health. 2021-03-20 - 1 citationsThe syndromic triad of COVID-19, type 2 diabetes, and malnutrition.Jeffrey I Mechanick, Elena A Christofides, Albert E Marchetti, Kristin K Hoddy, Jim Joachim
Frontiers in Nutrition. 2023-01-01
Journal Articles
- The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline CharacteristicsChristofides EA, Am J Nephrol, 1/1/2017
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary SyndromeChristofides EA, N Engl J Med, 1/1/2015
- Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide ve...Christofides EA, Am Heart J, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Cushing�s syndrome misdiagnosed as bipolar depressionChristofides, Pesa, Ngyuen, Endocrine Society, 1/1/2016
- Real World Clinical Experience with Exenatide, a long term study on Weight and A1c ControlChristofides EA, ADA, 1/1/2009
- A rare case of an epinephrine secreting pheochromocytomaChristofides EA, American College of Physicians, 1/1/1997
- Join now to see all
Lectures
- An FDA-approved Oral Solution Test to Diagnose Adult Growth Hormone DeficiencyENDO 2019 - New Orleans, LA - 3/25/2019
- Screening for Hypogonadism in Type 2 Diabetic Males: A Comparison of Primary Care and Endocrinology Practices1/13/2011
- Diagnostic Dilemma: Revisiting the Diagnosis of Pituitary Neoplasms1/21/2010
- Join now to see all
Other
- Clinical Importance of Achieving Biochemical Control with Medical Therapy in Adult Patients with AcromegalyChristofides EA, Patient Preference and Adherence
1/13/2016 - The Truth About Bio-identical HormonesChristofides EA, The First Messenger
1/1/2008 - Position Statement on Hormone Replacement Therapy (HRT) and Cardiovascular RiskChristofides EA, The First Messenger
1/1/2008 - Join now to see all
Press Mentions
- Pandemic Sees One-Quarter of Investigators Halting Trial Enrollment: PollMarch 31st, 2020
- Coronavirus Will Slow down Global Drug Development, Says New SurveyMarch 26th, 2020
- Common Chemical May Be Linked to Osteoporosis in WomenJune 24th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: